Sexual dysfunction associated with major depressive disorder and antidepressant treatment

Expert Opinion on Drug Safety

Volumn 13, Issue 10, 2014, Pages 1361-1374

  Clayton, Anita H ^a   El Haddad, Saria ^b   Iluonakhamhe, Josepha Pearl ^b   Ponce Martinez, Caridad ^b   Schuck, Alexandra Elizabeth ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Antidepressant associated sexual dysfunction; Major depressive disorder; Selective serotonin reuptake inhibitors; Serotonin and norepinephrine reuptake inhibitors; Sexual dysfunction; Treatment emergent sexual dysfunction

Indexed keywords

AMANTADINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIDOTE; APOMORPHINE; BUSPIRONE; CLOMIPRAMINE; DESVENLAFAXINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; GINKGO BILOBA EXTRACT; MIANSERIN; MIRTAZAPINE; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PLACEBO; REBOXETINE; SELEGILINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TRAZODONE; VENLAFAXINE; VILAZODONE; VORTIOXETINE; YOHIMBINE;

ANORGASMIA; ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; HEREDITY; HUMAN; MAJOR DEPRESSION; NONHUMAN; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; QUALITY OF LIFE; REMISSION; RISK FACTOR; SEXUAL DYSFUNCTION; SEXUALITY; ANIMAL; CHEMICALLY INDUCED; COMPARATIVE STUDY; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; GENETIC PREDISPOSITION; MEDICATION COMPLIANCE; PRACTICE GUIDELINE; PSYCHOLOGICAL RATING SCALE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEDICATION ADHERENCE; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 84907259277     PISSN: 14740338     EISSN: 1744764X     Source Type: Journal    
DOI: 10.1517/14740338.2014.951324     Document Type: Article

References (142)

1. Reichenpfader U, Gartlehner G, Morgan LC, et al. Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-Analysis. Drug saf 2014;37(1):19-31
2. Bromet E, Andrade LH, Hwang I, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 2011;9:90
3. Clayton A. The impact of antidepressantassociated sexual dysfunction on treatment adherence in patients with major depressive disorder. Curr Psychiatry Rev 2013;9:293-301
4. Shim RS, Baltrus P, Ye J, Rust G. Prevalence, treatment, and control of depressive symptoms in the United States: results from the National Health and Nutrition Examination Survey (NHANES), 2005-2008. J Am Board Fam Med 2011;24(1):33-8
5. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289(23):3095-105
6. Johannes CB, Clayton AH, Odom DM, et al. Distressing sexual problems in United States women revisited: prevalence after accounting for depression. J Clin Psychiatry 2009;70(12):1698-706
7. Bonierbale M, Lancon C, Tignol J. The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin 2003;19(2):114-24
8. Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol 2009;29(2):157-64
9. Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol 1998;13(Suppl 6):S1-4
10. Mathew RJ, Weinman ML. Sexual dysfunctions in Depression. Arch Sex Behav 1982;11(4):323-8
11. First MB, Frances A, Pincus HA. DSM-IV-TR handbook of differential diagnosis. American Psychiatric Publishing, Inc, Arlington VA; 2002
12. Association AP. DSM 5. American Psychiatric Association, Washington, DC; 2013
13. Organization WH. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva; 1992
14. Fooladi E, Bell RJ, Davis SR. Management strategies in SSRI-Associated sexual dysfunction in women at midlife. Climacteric 2012;15(4):306-16
15. Laurent SM, Simons AD. Sexual dysfunction in Depression and anxiety: conceptualizing sexual dysfunction as part of an internalizing dimension. Clin Psychol Rev 2009;29(7):573-85
16. Bartlik B, Kocsis JH, Legere R, et al. Sexual dysfunction secondary to depressive disorders. J Gend Specif Med 1999;2(2):52-60
17. Heiman JR. Sexual dysfunction: overview of prevalence, etiological factors, and treatments. J Sex Res 2002;39(1):73-8
18. Atlantis E, Sullivan T. Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis. J Sex Med 2012;9(6):1497-507
19. Bossini L, Fagiolini A, Valdagno M, et al. Sexual disorders in subjects treated for mood and anxiety diseases. J Clin Psychopharmacol 2007;27(3):310-12
20. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001;62(Suppl 3):10-21
21. Duenas H, Brnabic AJ, Lee A, et al. Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period. Int J Psychiatry Clin Pract 2011;15(4):242-54
22. Kennedy SH, Dickens SE, Eisfeld BS, Bagby RM. Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord 1999;56(2-3):201-8
23. Rothschild AJ. Sexual side effects of antidepressants. J Clin Psychiatry 2000;61(Suppl 11):28-36
24. Clayton AH, Pradko JF, Croft HA, et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002;63(4):357-66
25. Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-Analysis. J Clin Psychopharmacol 2009;29(3):259-66
26. Clayton AH, Montejo AL. Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry 2006;67(Suppl 6):33-7
27. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999;19(1):67-85
28. Derogatis LR. Sexual function and quality of life: endpoints and outcomes. J Gend Specif Med 2001;4(4):35-42
29. Rothschild AJ. New directions in the treatment of antidepressant-induced sexual dysfunction. Clin Ther 2000;22(Suppl A):A42-57; discussion A8-61
30. Zajecka JM. Clinical issues in long-Term treatment with antidepressants. J Clin Psychiatry 2000;61(Suppl 2):20-5
31. Montejo-Gonzalez AL, Llorca G, Izquierdo JA, et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J sex Marital Ther 1997;23(3):176-94
32. Ashton AK, Jamerson BD, Wagoner C, et al. Antidepressant-related adverse effects impacting treatment compliance: results of a patient survey. Curr Ther Res Clin Exp 2005;66(2):96-106
33. Venturini F, Sung JC, Nichol MB, Sellner JC. Utilization patterns of antidepressant medications in patient population served by primary care medical group. J Manag Care Pharm 1999;5(3):243-9
34. Croft H, Settle E Jr, Houser T, et al. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 1999;21(4):643-58
35. Hirschfeld RM. Sexual dysfunction in Depression: disease- or drug-related?. Depress Anxiety 1998;7(Suppl 1):21-3
36. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281(6):537-44
37. Seftel AD, Sun P, Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 2004;171(6 Pt 1):2341-5
38. Seidman SN. The aging male: androgens, erectile dysfunction, and depression. J Clin Psychiatry 2003;64(Suppl 10):31-7
39. Bergmark K, Avall-Lundqvist E, Dickman PW, et al. Synergy between sexual abuse and cervical cancer in causing sexual dysfunction. J sex Marital ther 2005;31(5):361-83
40. Whiffen VE, Macintosh HB. Mediators of the link between childhood sexual abuse and emotional distress: a critical review. Trauma Violence Abuse 2005;6(1):24-39
41. Arnow BA. Relationships between childhood maltreatment, adult health and psychiatric outcomes, and medical utilization. J Clin Psychiatry 2004;65(Suppl 12):10-15
42. Roesler TA, McKenzie N. Effects of childhood trauma on psychological functioning in adults sexually abused as children. J Nerv Ment Dis 1994;182(3):145-50
43. Lunde I, Ortmann J. Prevalence and sequelae of sexual torture. Lancet 1990;336(8710):289-91
44. Perelman MA. The sexual tipping point: a mind/body model for sexual medicine. J Sex Med 2009;6(3):629-32
45. Georgiadis JR, Kringelbach ML. The human sexual response cycle: brain imaging evidence linking sex to other pleasures. Prog Neurobiol 2012;98(1):49-81
46. Graf H, Walter M, Metzger CD, Abler B. Antidepressant-related sexual dysfunction - perspectives from neuroimaging. Pharmacol Biochem Behav 2014;121:138-45
47. Redoute J, Stoleru S, Gregoire MC, et al. Brain processing of visual sexual stimuli in human males. Hum Brain Mapp 2000;11(3):162-77
48. Moulier V, Mouras H, Pelegrini-Issac M, et al. Neuroanatomical correlates of penile erection evoked by photographic stimuli in human males. Neuroimage 2006;33(2):689-99
49. Fisher HE, Aron A, Brown LL. Romantic love: a mammalian brain system for mate choice. Philos Trans R Soc Lond B Biol Sci 2006;361(1476):2173-86
50. Mouras H, Stoleru S, Bittoun J, et al. Brain processing of visual sexual stimuli in healthy men: a functional magnetic resonance imaging study. Neuroimage 2003;20(2):855-69
51. Walter M, Matthia C, Wiebking C, et al. Preceding attention and the dorsomedial prefrontal cortex: process specificity versus domain Dependence. Hum Brain Mapp 2009;30(1):312-26
52. Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000;57(11):1012-30
53. Stahl SM. The psychopharmacology of sex, Part 1: neurotransmitters and the 3 phases of the human sexual response. J Clin Psychiatry 2001;62(2):80-1
54. Frohlich PF, Meston CM. Evidence that serotonin affects female sexual functioning via peripheral mechanisms. Physiol Behav 2000;71(3-4):383-93
55. Hull EM, Muschamp JW, Sato S. Dopamine and serotonin: influences on male sexual behavior. Physiol Behav 2004;83(2):291-307
56. Allard J, Truitt WA, McKenna KE, Coolen LM. Spinal cord control of ejaculation. World J Urol 2005;23(2):119-26
57. Montgomery SA, Baldwin DS, Riley A. Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord 2002;69(1-3):119-40
58. Thase ME, Clayton AH, Haight BR, et al. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. J Clin Psychopharmacol 2006;26(5):482-8
59. Kennedy SH, Rizvi S, Fulton K, Rasmussen J. A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. J Clin Psychopharmacol 2008;28(3):329-33
60. Clayton AH, Kornstein SG, Rosas G, et al. An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder. CNS Spectr 2009;14(4):183-95
61. Clayton AH TK, Focht K, Hwang E, et al. Desvenlafaxine 50 and 100mg/d vs placebo for the treatment of major dperesive disorder: a phase 4, randomized controlled trial. J Clin Psychiatry 2013;In press
62. Clayton A, Kornstein S, Prakash A, et al. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 2007;4(4 Pt 1):917-29
63. Reimherr FW, Chouinard G, Cohn CK, et al. Antidepressant efficacy of sertraline: a double-blind, placebo- And amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 1990;51(Suppl B):18-27
64. Leucht C, Huhn M, Leucht S. Amitriptyline versus placebo for major depressive disorder. Cochrane Database Syst Rev 2012;12:CD009138
65. Monteiro WO, Noshirvani HF, Marks IM, Lelliott PT. Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial. Br J Psychiatry 1987;151:107-12
66. Philipp M, Kohnen R, Benkert O. A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. Int Clin Psychopharmacol 1993;7(3-4):149-53
67. Clayton AH, Campbell BJ, Favit A, et al. Symptoms of sexual dysfunction in patients treated for major depressive disorder: a meta-Analysis comparing selegiline transdermal system and placebo using a patient-rated scale. J Clin Psychiatry 2007;68(12):1860-6
68. Frecska E. [Trazodone-its multifunctional mechanism of action and clinical use]. Neuropsychopharmacologia Hung 2010;12(4):477-82
69. Fagiolini A, Comandini A, Catena DellOsso M, Kasper S. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs 2012;26(12):1033-49
70. Stryjer R, Spivak B, Strous RD, et al. Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label study. Clin Neuropharmacol 2009;32(2):82-4
71. Atmaca M, Korkmaz S, Topuz M, Mermi O. Mirtazapine augmentation for selective serotonin reuptake inhibitorinduced sexual dysfunction: a retropective investigation. Psychiatry Invest 2011;8(1):55-7
72. Gelenberg AJ, McGahuey C, Laukes C, et al. Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry 2000;61(5):356-60
73. Gregorian RS, Golden KA, Bahce A, et al. Antidepressant-induced sexual dysfunction. Ann Pharmacother 2002;36(10):1577-89
74. Coleman CC, King BR, Bolden-Watson C, et al. A placebocontrolled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther 2001;23(7):1040-58
75. Coleman CC, Cunningham LA, Foster VJ, et al. Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. Ann Clin Psychiatry 1999;11(4):205-15
76. Segraves RT, Kavoussi R, Hughes AR, et al. Evaluation of sexual functioning in Depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment. J Clin Psychopharmacol 2000;20(2):122-8
77. Merims D, Giladi N. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease. Parkinsonism Relat Disord 2008;14(4):273-80
78. Assem-Hilger E, Kasper S. Psychopharmaka und sexuelle dysfunktion. J Neurol Neurochir Psychiatry 2005;6:30-6
79. Clayton AH, Zajecka J, Ferguson JM, et al. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol 2003;18(3):151-6
80. Baldwin D, Bridgman K, Buis C. Resolution of sexual dysfunction During double-blind treatment of major depression with reboxetine or paroxetine. J Psychopharmacol 2006;20(1):91-6
81. Bishop JR, Moline J, Ellingrod VL, et al. Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-Associated sexual side-effects. Neuropsychopharmacology 2006;31(10):2281-8
82. Masiran R, Sidi H, Mohamed Z, et al. Association between 5HT2A polymorphism and selective serotonin re-uptake inhibitor (SSRI)-induced sexual desire disorder (SDD) among Malaysian women. Asia Pac Psychiatry 2013;5(Suppl 1):41-9
83. Bishop JR, Ellingrod VL, Akroush M, Moline J. The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-Associated sexual side effects: possible relationship to oral contraceptives. Hum Psychopharmacol 2009;24(3):207-15
84. Perlis RH, Laje G, Smoller JW, et al. Genetic and clinical predictors of sexual dysfunction in citalopram-Treated depressed patients. Neuropsychopharmacology 2009;34(7):1819-28
85. Kurose K, Hiratsuka K, Ishiwata K, et al. Genome-wide association study of SSRI/ SNRI-induced sexual dysfunction in a Japanese cohort with major depression. Psychiatry Res 2012;198(3):424-9
86. van Den Oord EJ, Kuo PH, Hartmann AM, et al. Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism. Arch Gen Psychiatry 2008;65(9):1062-71
87. Zourkova A, Ceskova E, Hadasova E, Ravcukova B. Links among paroxetineinduced sexual dysfunctions, gender, and CYP2D6 activity. J Sex Marital Ther 2007;33(4):343-55
88. Bly MJ, Bishop JR, Thomas KL, Ellingrod VL. P-glycoprotein (PGP) polymorphisms and sexual dysfunction in female patients with depression and SSRI-Associated sexual side effects. J Sex Marital Ther 2013;39(3):280-8
89. McGahuey CA, Gelenberg AJ, Laukes CA, et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 2000;26(1):25-40
90. Clayton AH, McGarvey EL, Clavet GJ. The changes in sexual functioning questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull 1997;33(4):731-45
91. Montejo AL, Garcia M, Espada M, et al. [Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish work group for the study of psychotropic-related sexual dysfunctions]. Actas Esp Psiquiatr 2000;28(3):141-50
92. Kennedy SH, Fulton KA, Bagby RM, et al. Sexual function During bupropion or paroxetine treatment of major depressive disorder. Can J Psychiatry 2006;51(4):234-42
93. Kennedy SH, Eisfeld BS, Dickens SE, et al. Antidepressant-induced sexual dysfunction During treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 2000;61(4):276-81
94. Baldwin DS, Foong T. Antidepressant drugs and sexual dysfunction. Br J Psychiatry 2013;202:396-7
95. Regulatory science forum on measuring sexual dysfunction in Depression trials. Washington D.C: 2012
96. Balon R, Segraves RT. Survey of treatment practices for sexual dysfunction (s) associated with anti-depressants. J Sex Marital Ther 2008;34(4):353-65
97. El-Sakka AI. Erectile dysfunction, depression, and ischemic heart disease: does the existence of one component of this triad necessitate inquiring the other two?. J Sex Med 2011;8(4):937-40.quiz 41
98. Organization WH. Health topics: Sexual health. World Health Organization; Geneva: 2011
99. La Torre A, Giupponi G, Duffy D, Conca A. Sexual dysfunction related to psychotropic drugs: a critical review-part I: antidepressants. Pharmacopsychiatry 2013;46(5):191-9
100. Baldwin DS. Depression and sexual dysfunction. Br Med Bull 2001;57:81-99
101. Bahrick AS, Harris MM. Sexual side effects of antidepressant medications: an informed consent accountability gap. J Contemp Psychother 2009;39(2):135-43
102. Balon R. SSRI-Associated sexual dysfunction. Am J Psychiatry 2006;163(9):1504-9.quiz 664
103. Labbate LA, Croft HA, Oleshansky MA. Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation. J Clin Psychiatry 2003;64(Suppl 10):11-19
104. Nurnberg HG, Levine PE. Spontaneous remission of MAOI-induced anorgasmia. Am J Psychiatry 1987;144(6):805-7
105. Rothschild AJ. Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry 1995;152(10):1514-16
106. Montejo A, Majadas S, Rizvi SJ, Kennedy SH. The effects of agomelatine on sexual function in Depressed patients and healthy volunteers. Hum Psychopharmacol 2011;26(8):537-42
107. Baldwin DS, Loft H, Dragheim M. A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD). Eur Neuropsychopharmacol 2012;22(7):482-91
108. Khan A, Cutler AJ, Kajdasz DK, et al. A randomized, double-blind, placebocontrolled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder. J Clin Psychiatry 2011;72(4):441-7
109. Gartlehner G, Hansen RA, Morgan LC, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-Analysis. Ann Intern Med 2011;155(11):772-85
110. Clayton AH, Croft HA, Horrigan JP, et al. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 2006;67(5):736-46
111. Safarinejad MR. Reversal of SSRIinduced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebocontrolled and randomized study. J Psychopharmacol 2011;25(3):370-8
112. Clayton AH, Warnock JK, Kornstein SG, et al. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitorinduced sexual dysfunction. J Clin Psychiatry 2004;65(1):62-7
113. DeBattista C, Solvason B, Poirier J, et al. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry 2005;66(7):844-8
114. Saiz-Ruiz J, Montes JM, Ibanez A, et al. Assessment of sexual functioning in Depressed patients treated with mirtazapine: a naturalistic 6-month study. Hum Psychopharmacol 2005;20(6):435-40
115. Ozmenler NK, Karlidere T, Bozkurt A, et al. Mirtazapine augmentation in Depressed patients with sexual dysfunction Due to selective serotonin reuptake inhibitors. Hum Psychopharmacol 2008;23(4):321-6
116. Landen M, Eriksson E, Agren H, Fahlen T. Effect of buspirone on sexual dysfunction in Depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999;19(3):268-71
117. Michelson D, Bancroft J, Targum S, et al. Female sexual dysfunction associated with antidepressant administration: a randomized, placebocontrolled study of pharmacologic intervention. Am J Psychiatry 2000;157(2):239-43
118. Clayton AH, Kennedy SH, Edwards JB, et al. The effect of vilazodone on sexual function During the treatment of major depressive disorder. J Sex Med 2013;10(10):2465-76
119. Jacobson PL, Mahableshwarkar AR, Palo W, et al. editor. The effect of vortioxetine on sexual dysfunction in adults with major depressive disorder or generalized anxiety disorder. ASCP meeting, May 28, 2014
120. Jacobsen PL MA, Chen Y, Chrones L, Clayton AH. editor. A head-To-head, randomized comparison study of vortioxetine vs. escitalopram in patients well treated for major depressive disorder and experiencing treatment-emergent sexual dysfunction. ASCP meeting, May 28, 2014
121. Ahn GJ, Kang KK, Kim DS, et al. DA-8159 reverses selective serotonin reuptake inhibitor-induced erectile dysfunction in rats. Urology 2005;65(1):202-7
122. Sukoff Rizzo SJ, Schechter LE, Rosenzweig-Lipson S. A novel approach for predicting antidepressant-induced sexual dysfunction in rats. Psychopharmacology (Berl) 2008;195(4):459-67
123. Nurnberg HG, Hensley PL, Gelenberg AJ, et al. Treatment of antidepressant-Associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA 2003;289(1):56-64
124. Nurnberg HG, Hensley PL, Heiman JR, et al. Sildenafil treatment of women with antidepressant-Associated sexual dysfunction: a randomized controlled trial. JAMA 2008;300(4):395-404
125. Amiaz R, Pope HG Jr, Mahne T, et al. Testosterone gel replacement improves sexual function in Depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther 2011;37(4):243-54
126. Schweitzer I, Maguire K, Ng C. Sexual side-effects of contemporary antidepressants: review. Aust N Z J Psychiatry 2009;43(9):795-808
127. Lorenz TA, Meston CM. Acute exercise improves physical sexual arousal in women taking antidepressants. Ann Behav Med 2012;43(3):352-61
128. Lorenz TA, Meston CM. Exercise improves sexual function in women taking antidepressants: results from a randomized crossover trial. Depress Anxiety 2014;31(3):188-95
129. Shin BC, Lee MS, Yang EJ, et al. Maca (L. meyenii) for improving sexual function: a systematic review. BMC Complement Altern Med 2010;10:44
130. Dording CM, Fisher L, Papakostas G, et al. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neurosci Ther 2008;14(3):182-91
131. Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital ther 1998;24(2):139-43
132. Balon R. Ginkgo biloba for antidepressant-induced sexual dysfunction?. J Sex Marital ther 1999;25(1):1-2
133. Levine SB. Caution recommended. J Sex Marital ther 1999;25(1):2-5
134. Meston CM, Rellini AH, Telch MJ. Short- And long-Term effects of Ginkgo biloba extract on sexual dysfunction in women. Arch Sex Behav 2008;37(4):530-47
135. Wheatley D. Triple-blind, placebocontrolled trial of Ginkgo biloba in sexual dysfunction Due to antidepressant drugs. Hum Psychopharmacol 2004;19(8):545-8
136. Kang BJ, Lee SJ, Kim MD, Cho MJ. A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressantinduced sexual dysfunction. Hum Psychopharmacol 2002;17(6):279-84
137. Dording CM, Mischoulon D, Shyu I, et al. SAMe and sexual functioning. Eur Psychiatry 2012;27(6):451-4
138. Kashani L, Raisi F, Saroukhani S, et al. Saffron for treatment of fluoxetineinduced sexual dysfunction in women: randomized double-blind placebocontrolled study. Hum Psychopharmacol 2013;28(1):54-60
139. Khamba B, Aucoin M, Lytle M, et al. Efficacy of acupuncture treatment of sexual dysfunction secondary to antidepressants. J Altern Complement Med 2013;19(11):862-9
140. Fooladi E, Davis SR. An update on the pharmacological management of female sexual dysfunction. Expert Opin Pharmacother 2012;13(15):2131-42
141. Basson R. Pharmacotherapy for women's sexual dysfunction. Expert Opin Pharmacother 2009;10(10):1631-48
142. Brotto LA, Bitzer J, Laan E, et al. Women's sexual desire and arousal disorders. J Sex Med 2010;7(1 Pt 2):586-614